Press release
Decentralized Clinical Trials Market Accelerates Amid Shift to Remote Monitoring Technologies 2025-2033 | ICON plc, Parexel International Corporation, Laboratory Corporation of America Holdings
Decentralized Clinical Trials Market
The latest Decentralized Clinical Trials market research report from DataM Intelligence delivers a comprehensive analysis of the global Decentralized Clinical TrialsMarket landscape, highlighting emerging trends, market size, competitive dynamics, and key growth drivers. By leveraging advanced analytics, technology trend mapping, and regulatory assessment, the report highlights emerging growth drivers, evolving care models, and investment opportunities. It equips stakeholders with strategic intelligence essential for navigating the complex healthcare ecosystem from clinical innovation to operational efficiency across the forecast period 2024-2031.
Download exclusive insights with our detailed sample report (Corporate Email ID gets priority access):
https://www.datamintelligence.com/download-sample/decentralized-clinical-trials-market?ophp
Decentralized Clinical Trials (DCTs) are conducted remotely using digital tools such as apps and wearable sensors, allowing participants to take part from home. The market is expanding rapidly as sponsors seek more inclusive, cost-effective, and patient-centric trial models.
Comprehensive Insight into Decentralized Clinical Trials Market Landscape and Growth Trends:
Top Companies
ICON plc, Parexel International Corporation, Laboratory Corporation of America Holdings, Medpace, Inc., Science 37, THREAD, Inc., Curebase, Castor, IQVIA Inc., and Medable Inc., among others.
Emerging Players
The emerging players in the decentralized clinical trials market include Veeva Systems Inc., PRAXIS, Advarra, The Emmes Company, LLC, and Syneos Health, among others.
Important Mergers, Acquisitions, and Market Shifts:
In May 2025, ABM Respiratory Care, an innovator in respiratory therapy solutions, announced the initiation of a multi-center home care study in collaboration with Delve Health, a trailblazer in decentralized clinical trial technology, to evaluate the impact of its BiWaze Clear System in patients living with bronchiectasis. The study will assess how the BiWaze Clear System affects respiratory health over six months.
In October 2024, Adaptive Research, a clinical trial site organization dedicated to democratizing clinical trials, announced its participation in a groundbreaking decentralized study for Parkinson's Disease sponsored by PhotoPharmics Inc. California Movement Disorders Center, part of Adaptive Research's network, will serve as a site for PhotoPharmics' LIGHT-PD trial, testing the efficacy of Celeste Specialized Phototherapy in treating Parkinson's symptoms.
In August 2024, Walgreens and the Biomedical Advanced Research and Development Authority (BARDA) announced a strategic partnership to increase innovation in decentralized clinical trials as part of the Decentralized Clinical Operations for Healthcare and Research (D-COHRe) program. The program is designed to strengthen U.S. decentralized clinical research capabilities to support the development of U.S. Food and Drug Administration (FDA)-regulated products, enhance clinical innovation to execute more efficient and relevant clinical research, and evaluate other medical countermeasures in real-world environments that may be used in a public health emergency.
Market Drivers:
A shift toward patient-centric models, cost-efficient operations, and remote monitoring capabilities is pushing the growth of decentralized clinical trial solutions.
Decentralized Clinical Trials Market Segments:
By Study Type (Interventional Trials, Observational Trials, Expanded Access Trials, Others)
By Component (Software Solutions, Hardware Solutions)
By Therapeutic Area ( Oncology, Cardiovascular Diseases, Infectious Diseases, Respiratory Diseases, Neurology, Rare Diseases, Metabolic Disorders, Others)
By End-User ( Pharmaceutical and Biotechnology Companies, Contract Research Organizations, Academic and Research Institutes, Others)
Speak to Our Analyst and Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/decentralized-clinical-trials-market?ophp
Methodology and Scope:
This Decentralized Clinical Trials Market report is developed using a robust research methodology that combines primary interviews, insights from industry experts, and verified secondary sources such as company filings, trade journals, and trusted databases. It follows a bottom-up and top-down approach to ensure data accuracy through triangulation. The scope of the report covers current market trends, growth potential, and strategic developments across global and regional markets.
Regional Overview for Decentralized Clinical Trials Market:
⇥ North America (U.S., Canada, Mexico)
⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
⇥ South America (Colombia, Brazil, Argentina, Rest of South America)
⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)
Looking For Exclusive Full Report? Get it here: https://www.datamintelligence.com/buy-now-page?report=decentralized-clinical-trials-market?ophp
The Report Includes:
➡ A descriptive analysis of demand-supply gap, market size estimation, SWOT analysis, PESTEL Analysis and forecast in the global market.
➡ Go-to-market Strategy.
➡ Neutral perspective on the market performance.
➡ Customized regional/country reports as per request and country level analysis.
➡ Potential & niche segments and regions exhibiting promising growth covered.
People Also Ask:
➠ What are the global sales, production, consumption, imports, and exports in the Decentralized Clinical Trials market?
➠ Who are the top manufacturers, and what are their capacity, production, sales, pricing, and revenue stats?
➠ What key opportunities and challenges do vendors face in the Decentralized Clinical Trials industry?
➠ Which product types, applications, or end-users are driving market growth, and what is their market share?
➠ What are the major growth drivers and restraints of the Decentralized Clinical Trials market?
Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com
About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Decentralized Clinical Trials Market Accelerates Amid Shift to Remote Monitoring Technologies 2025-2033 | ICON plc, Parexel International Corporation, Laboratory Corporation of America Holdings here
News-ID: 4089902 • Views: …
More Releases from DataM intelligence 4 Market Research LLP
United States Fertilizer Mixtures Market to Grow at 9.23% CAGR by 2030 | Asia-Pa …
Fertilizer Mixtures Market Overview
The Global Fertilizer Mixtures Market is projected to grow at a CAGR of 9.23% during the forecast period 2023-2030. Fertilizer mixtures are physical combinations of straight fertilizers, containing two or more primary plant nutrients such as nitrogen (N), phosphorus (P), and potassium (K). These mixtures are produced by mechanically or manually blending individual fertilizer components, ensuring uniform nutrient distribution and enhanced soil fertility.
The market growth is being…
United States Cleaning Robots Market to Reach US$ 14.9 Billion by 2032, Led by N …
The US Cleaning Robots Market was US$ 2,661.68 million in 2024 and is expected to reach US$ 14,889.06 million in 2032 growing at a CAGR of 24.2% during the forecast period (2025-2032).
DataM Intelligence unveils its latest report on the "US Cleaning Robot Market Size 2025," offering an in-depth analysis of market trends, growth drivers, competitive landscape, and regional dynamics. The study covers market size in value and volume, CAGR forecasts,…
Uveitis Treatment Market to Reach US$ 1,258.35million | CAGR 5.5% | North Americ …
Uveitis Treatment Market Size
The global uveitis treatment market reached US$ 742.09 million in 2023 and grew to US$ 779.75 million in 2024. It is projected to reach US$ 1,258.35 million by 2033, expanding at a CAGR of 5.5% during the forecast period 2025-2033.
Market growth is being driven by the increasing awareness and early diagnosis of ocular disorders, coupled with advancements in imaging technologies and therapeutic options. For instance, a 2024…
United States Smart Thermostat Market 2031 | Growth Drivers, Key Players & Inves …
Market Size and Growth
Smart Thermostat Market is growing with a High CAGR during the forecast period 2024-2031.
Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://www.datamintelligence.com/download-sample/smart-thermostat-market?sb
Key Development:
United States: Recent Smart Thermostat Developments
✅ In January 2026, Eve Systems debuted its first‐ever smart thermostat at CES 2026, a Matter‐over‐Thread compatible device focused on privacy‐first operation with no cloud or subscription required, remote control via major…
More Releases for Trials
Clinical Trials Management System Market Trends: How Decentralized Clinical Tria …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Clinical Trials Management System Market Size, Share & Trends Analysis Report By Solution Type (Enterprise and Site based), By Delivery Mode (Web & Cloud-based, On-premise), By Component (Software, Services), By End-user (Pharmaceutical and Biotechnology Firms, Medical Device Firms, CROs)- Market Outlook And Industry Analysis 2031"
The global Clinical Trials Management System market is estimated to reach…
Brazil Clinical Trials Market ANVISA Brazil Guidelines Brazil Clinical Trials Re …
Brazil Cancer Drugs Clinical Trials Insight 2024 Report Offering:
• Brazil Clinical Trials Market Opportunity 2024 and 2030 (In US$ Billion)
• Clinical Trials Regulatory Framework In Brazil
• Total Number of Cancer Drugs In Clinical Trials In Brazil
• Total Number Of Cancer Drugs Approved In Brazil
• 400 Pages Clinical Trials Insight On All Cancer Drugs In Clinical Trials By Company, Indication and Phase
• 80 Pages Clinical Insight On All Cancer Drugs Approved in Market By Company and Indication
• Insight…
Clinical Trials Management System Market Clinical Trials Management System Marke …
InsightAce Analytic announces the release of a market assessment report on the "Global Clinical Trials Management System Market Size, Share & Trends Analysis Report By Solution Type (Enterprise and Site based), By Delivery Mode (Web & Cloud-based, On-premise), By Component (Software, Services), By End-user (Pharmaceutical and Biotechnology Firms, Medical Device Firms, CROs)- Market Outlook And Industry Analysis 2031.
The global Clinical Trials Management System market is estimated to reach over USD…
Revolutionizing Clinical Trials: The Evolution of eCOA, eSource, and the Clinica …
The global eCOA, eSource & clinical trials market is valued at US$ 48 billion in 2023 and is expected to reach a market size of US$ 104 billion by the end of 2033, expanding rapidly at a CAGR of 8% over the next ten years. Worldwide demand for eCOA (electronic clinical outcome assessment) solutions is predicted to rise at a CAGR of 8.2% over the forecast period.
In the dynamic landscape…
Virtual Clinical Trials Market - Bridging the Gap: Virtual Clinical Trials Revol …
Newark, New Castle, USA - The latest report from Growth Plus Reports analyzes the production, potential applications, demand, major manufacturers, and SWOT analysis of the global Virtual Clinical Trials Market.
Virtual Clinical Trials Market: https://www.growthplusreports.com/report/virtual-clinical-trials-market/9106
The Virtual Clinical Trials Market Report assists in determining the optimum distribution methods for certain products as well as possible markets for future product launches. The report also analyses the purchase and supply trends that influence the…
Clinical Trials Market: Coronavirus Pandemic Pushes Sponsors, Patients to Adopt …
Clinical trials Market: Introduction
According to the report, the global clinical trials market was valued over US$ 46.7 Bn in 2019 and is projected to expand at a CAGR of ~5% from 2020 to 2030. High prevalence and increase in incidence rate of chronic diseases, and rise in R&D activities in biotechnology & pharmaceuticals industries are anticipated to drive the global clinical trials market from 2020 to 2030. North America is projected to…
